Insider Trading & Ownership of Braden M. Leonard
-
Location
-
Zionsville, IN
-
Summary
-
The estimated net worth of Braden M. Leonard is at least $447,785,203 dollars as of 04 Mar 2026. Braden M. Leonard is the 10%+ Owner of Gemini Therapeutics, Inc. /DE and owns shares of Disc Medicine, Inc. (IRON) stock worth about $354.99M. Braden M. Leonard is the 10%+ Owner of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $30.24M. Braden M. Leonard is the 10%+ Owner of Aclaris Therapeutics, Inc. and owns shares of Aclaris Therapeutics, Inc. (ACRS) stock worth about $17.73M. Braden M. Leonard is the 10%+ Owner of Cyteir Therapeutics, Inc. and owns shares of Cyteir Therapeutics, Inc. stock worth about $11.77M. Braden M. Leonard is the 10%+ Owner of Adverum Biotechnologies, Inc. and owns shares of Adverum Biotechnologies, Inc. (ADVM) stock worth about $9.03M. Braden M. Leonard is the 10%+ Owner of Outset Medical, Inc. and owns shares of Outset Medical, Inc. (OM) stock worth about $8.64M. Braden M. Leonard is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $6M. Braden M. Leonard is the 10%+ Owner of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $3.29M. Braden M. Leonard is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $3.18M. Braden M. Leonard is the 10%+ Owner of RETRACTABLE TECHNOLOGIES INC and owns shares of RETRACTABLE TECHNOLOGIES INC (RVP) stock worth about $1.32M. Braden M. Leonard is the Former 10% owner of RPHM of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $670.1K. Braden M. Leonard is the Former 10% owner of AVROBIO of Tectonic Therapeutic, Inc. and owns shares of Tectonic Therapeutic, Inc. (TECX) stock worth about $563.8K. Braden M. Leonard is the 10%+ Owner of Talis Biomedical Corp and owns shares of Talis Biomedical Corp (TLIS) stock worth about $369.1K.
-
Signature
-
Braden M Leonard
Follow Filing Activity
Follow Braden M. Leonard and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Braden M. Leonard has 14 issuer positions tracked on this page.
- Estimated disclosed ownership value: $447,785,203.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Gemini Therapeutics, Inc. /DE ($354,993,375).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Braden M. Leonard
| Symbol |
Company |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Report Period |
| IRON |
Gemini Therapeutics, Inc. /DE |
10%+ Owner |
$354,993,375 |
|
|
26 Oct 2022 |
| ELVN |
IMARA Inc. |
10%+ Owner |
$30,236,309 |
|
|
03 Jan 2023 |
| ACRS |
Aclaris Therapeutics, Inc. |
10%+ Owner |
$17,731,275 |
|
|
02 Aug 2024 |
| CYT |
Cyteir Therapeutics, Inc. |
10%+ Owner |
$11,767,706 |
|
|
20 Mar 2024 |
| ADVM |
Adverum Biotechnologies, Inc. |
10%+ Owner |
$9,030,626 |
-$3,559,255 |
-28% |
04 Dec 2025 |
| OM |
Outset Medical, Inc. |
10%+ Owner |
$8,635,992 |
|
|
12 Feb 2026 |
| STSA |
Satsuma Pharmaceuticals, Inc. |
10%+ Owner |
$5,996,900 |
|
|
21 Nov 2022 |
| ANTX |
AN2 Therapeutics, Inc. |
10%+ Owner |
$3,289,000 |
-$3,090,477 |
-48% |
12 Jun 2025 |
| MTCR |
Metacrine, Inc. |
10%+ Owner |
$3,177,468 |
|
|
19 Dec 2022 |
| RVP |
RETRACTABLE TECHNOLOGIES INC |
10%+ Owner |
$1,323,572 |
|
|
29 Dec 2022 |
| OKUR |
Reneo Pharmaceuticals, Inc. |
Former 10% owner of RPHM |
$670,111 |
|
|
07 Oct 2024 |
| TECX |
Tectonic Therapeutic, Inc. |
Former 10% owner of AVROBIO |
$563,795 |
|
|
20 Jun 2024 |
| TLIS |
Talis Biomedical Corp |
10%+ Owner |
$369,074 |
|
|
05 Sep 2024 |
| ASTC |
ASTROTECH Corp |
10%+ Owner |
$0 |
-$1,625,071 |
-100% |
03 Oct 2025 |
Insider Transactions Reported by Braden M. Leonard:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.